Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 16
Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype
Andrej Kmetec, Jera Jeruc
Pregledni znanstveni članek
Oznake: onkologija;rak (medicina);ledvice;karcinom;diagnostika;
Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype
Leto: 2014 Vir: Onkološki inštitut Ljubljana (OI)
Napovedni pomen semikvantitativnega in kvantitativnega določanja proliferacijske aktivnosti pri raku dojke
Snežana Đokić, Jera Jeruc
Doktorska disertacija
Oznake: karcinom dojke;proliferacijska aktivnost;Ki-67;MIB-1;frakcija S-faze;proliferacija;napovedni dejavnik.;
Proliferacijska aktivnost (PA) je pomemben prognostični in prediktivni dejavnik pri karcinomu dojke. Klub temu, da je Ki-67 priznan označevalec PA v histoloških rezinah, je njegova uporaba v klinični praksi še vedno vprašljiva zaradi nestandardiziranih metod ocenjevanja in neenotne mejne vrednosti, ...
Leto: 2025 Vir: Medicinska fakulteta (UL MF)
Vitamin A and retinoids in bladder cancer chemoprevention and treatment
Larisa Tratnjek, Jera Jeruc, Rok Romih, Daša Zupančič
Pregledni znanstveni članek
Oznake: bladder cancer;vitamin A;retinoic acid signalling;
Bladder cancer (BC) is the tenth most common cancer worldwide with a high recurrence rate, morbidity and mortality. Therefore, chemoprevention and improved treatment of BC are of paramount importance. Epidemiological studies suggest that adequate vitamin A intake may be associated with reduced BC ri ...
Leto: 2021 Vir: Medicinska fakulteta (UL MF)
Long-term survival of a patient with liver metastases from clear cell gastric adenocarcinoma after multimodality treatment including interventional oncology techniques
Vesna Jugovec, Jernej Benedik, Jera Jeruc, Peter Popović
Kratki znanstveni prispevek
Oznake: adenokarcinom želodca;preživetje;multimodalno zdravljenje;gastric adenocarcinoma;survival;multimodality treatment;
Background: Gastric cancer (GC) is the fourth most common cancer and the third leading cancer-related cause of death worldwide since most patients are diagnosed at an advanced stage. The majority of GCs are adenocarcinomas (ACs), and the poorly characterized clear cell AC represents a unique subgrou ...
Leto: 2022 Vir: Onkološki inštitut Ljubljana (OI)
ǂThe ǂinterplay of dietary sugar, chronic inflammation, and bladder cancer
Larisa Tratnjek, Aleksandar Janev, Tadeja Kuret, Urška Dragin, Urška Dragin, Katja Lakota, Jera Jeruc
Pregledni znanstveni članek
Oznake: bladder cancer;chronic inflammation;dietary sugar;hyperglycaemia;lifestyle strategies;therapeutic approaches;
High dietary sugar intake has emerged as a key modulator of systemic inflammation and metabolic dysregulation, both of which are associated with an increased risk of several chronic diseases, including cancer. Although bladder cancer is primarily driven by factors such as smoking and occupational ex ...
Leto: 2026 Vir: Medicinska fakulteta (UL MF)
Management of adrenocortical carcinoma in Slovenia
Urška Bokal, Jera Jeruc, Tomaž Kocjan, Metka Volavšek, Janja Jerebic, Matej Rakuša, Marina Mencinger
Izvirni znanstveni članek
Oznake: adrenokortikalni karcinom;stopnja ENSAT;sistemsko zdravljenje;adrenocortical carcinoma;ENSAT stage;systemic treatment;
Background. Adrenocortical carcinoma (ACC) is a rare cancer that presents significant diagnostic and therapeutic challenges. We analyzed the management and estimated survival of ACC patients in Slovenia over a 17-year period. Patients and methods. Patients registered in the National Cancer Registry ...
Leto: 2025 Vir: Onkološki inštitut Ljubljana (OI)
Priporočila Onkološkega inštituta za obravnavo bolnikov z adenokarcinomom tankega črevesa
Erik Brecelj, Vesna Zadnik, Ksenija Strojnik, Nina Boc, Gorana Gašljević, Jera Jeruc, Gašper Pilko, Martina Reberšek, Franc Anderluh
Strokovni članek
Oznake: adenokarcinom tankega črevesa;priporočila;prebavni trakt;redki raki;
Priporočila Onkološkega inštituta za obravnavo bolnikov z adenokarcinomom tankega črevesa
Leto: 2021 Vir: Onkološki inštitut Ljubljana (OI)
Priporočila za obravnavo bolnikov z adenokarcinomom tankega črevesa
Erik Brecelj, Vesna Zadnik, Ksenija Strojnik, Nina Boc, Gorana Gašljević, Jera Jeruc, Gašper Pilko, Martina Reberšek, Franc Anderluh
Ni določena
Oznake: rak (medicina);epidemiologija;preventiva;dedna predispozicija;diagnostika;kirurško zdravljenje;adjuvantna terapija;sistemsko zdravljenje;radioterapija;sledenje pacientov;medicinska rehabilitacija;paliativna oskrba;elektronske knjige;
Priporočila za obravnavo bolnikov z adenokarcinomom tankega črevesa
Leto: 2021 Vir: Onkološki inštitut Ljubljana (OI)
Vitamin A rich diet diminishes early urothelial carcinogenesis by altering retinoic acid signaling
Daša Zupančič, Jelena Korać-Prlić, Mateja Erdani-Kreft, Lucija Franković, Katarina Vilović, Jera Jeruc, Rok Romih, Janoš Terzić
Izvirni znanstveni članek
Oznake: mehur;early carcinogenesis;vitamin A;urinary bladder;
Urinary bladder cancer is one of the leading malignancies worldwide, with the highest recurrence rates. A diet rich in vitamin A has proven to lower the risk of cancer, yet the molecular mechanisms underlying this effect are unknown. We found that vitamin A decreased urothelial atypia and apoptosis ...
Leto: 2020 Vir: Medicinska fakulteta (UL MF)
Smernice za zdravljenje bolnikov z rakom požiralnika in ezofagogastričnega stika
Erik Brecelj, Franc Anderluh, Marko Boc, Goran Gačevski, Gorana Gašljević, Samo Horvat, Nežka Hribernik, Marija Ignjatović, Ana Jeromen, Jera Jeruc
Strokovni članek
Oznake: rak požiralnika;smernice;onkologija;
Leto: 2022 Vir: Onkološki inštitut Ljubljana (OI)
Št. zadetkov: 16
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: